(Q36802635)

16 August 2017

1 reference

title

Monotherapy with lopinavir/ritonavir (English)

1 reference

16 August 2017

1 reference

1 reference

1

Mauro Schechter

1 reference

16 August 2017

author name string

Estevão Portela Nunes

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Investigational Drugs

16 August 2017

published in

1 reference

16 August 2017

volume

16

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

735-741

1 reference

Estimating HIV prevalence and the impact of HIV/AIDS on a Ugandan hospital by combining serosurvey data and hospital discharge records

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Access to antiretroviral drugs in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Lopinavir/ritonavir (ABT-378/r).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.5.735

10.1517/13543784.16.5.735

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference